In potential $1.6 billion deal, Gilead snags yet another Bay Area cancer target
July 21, 2020 at 08:30 AM EDT
A complex option transaction got more complicated when Gilead's South San Francisco-based target had to create a spinout to deal with another deal signed last year.
